Fengjun Guo

497 total citations
14 papers, 356 citations indexed

About

Fengjun Guo is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Fengjun Guo has authored 14 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Fengjun Guo's work include Endometrial and Cervical Cancer Treatments (3 papers), MicroRNA in disease regulation (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). Fengjun Guo is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), MicroRNA in disease regulation (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). Fengjun Guo collaborates with scholars based in China and United States. Fengjun Guo's co-authors include Manhua Cui, Yuemei Jin, Ling Wang, Lin Yang, Aamir Ahmad, Yanqing Li, Xiwen Zhang, Yingying Chen, Bingbing Yu and Jingyan Tian and has published in prestigious journals such as PLoS ONE, Carcinogenesis and Cancer Letters.

In The Last Decade

Fengjun Guo

14 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengjun Guo China 9 179 138 64 57 52 14 356
Guihai Ai China 11 344 1.9× 227 1.6× 69 1.1× 44 0.8× 64 1.2× 19 573
Zhiqin Fu China 12 254 1.4× 148 1.1× 38 0.6× 24 0.4× 96 1.8× 34 533
Juan Zou China 13 220 1.2× 51 0.4× 32 0.5× 32 0.6× 87 1.7× 30 405
Marcin Bobiński Poland 9 87 0.5× 47 0.3× 120 1.9× 48 0.8× 108 2.1× 30 480
Gabrielle Gossner United States 10 177 1.0× 70 0.5× 28 0.4× 58 1.0× 58 1.1× 14 389
Yingting Wu China 12 223 1.2× 75 0.5× 58 0.9× 14 0.2× 59 1.1× 26 465
Tengxiang Chen China 12 294 1.6× 181 1.3× 41 0.6× 38 0.7× 70 1.3× 48 516
Marwa Kamel Egypt 12 137 0.8× 65 0.5× 49 0.8× 91 1.6× 64 1.2× 21 384
Lei Dou China 13 214 1.2× 105 0.8× 41 0.6× 66 1.2× 48 0.9× 19 407
Jin Cao China 10 256 1.4× 208 1.5× 20 0.3× 25 0.4× 46 0.9× 14 440

Countries citing papers authored by Fengjun Guo

Since Specialization
Citations

This map shows the geographic impact of Fengjun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengjun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengjun Guo more than expected).

Fields of papers citing papers by Fengjun Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengjun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengjun Guo. The network helps show where Fengjun Guo may publish in the future.

Co-authorship network of co-authors of Fengjun Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Fengjun Guo. A scholar is included among the top collaborators of Fengjun Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengjun Guo. Fengjun Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wang, Yichao, et al.. (2023). Nanocarrier-based targeting of metabolic pathways for endometrial cancer: Status and future perspectives. Biomedicine & Pharmacotherapy. 166. 115348–115348. 8 indexed citations
2.
Wang, Yichao, et al.. (2022). Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian cancer through preclinical studies. Frontiers in Oncology. 12. 978603–978603. 5 indexed citations
3.
Xing, Dong, et al.. (2021). PSMA conjugated combinatorial liposomal formulation encapsulating genistein and plumbagin to induce apoptosis in prostate cancer cells. Colloids and Surfaces B Biointerfaces. 203. 111723–111723. 25 indexed citations
4.
Guo, Fengjun, Jingyan Tian, Yuemei Jin, et al.. (2021). [Retracted] Effects of cyclooxygenase‑2 gene silencing on the biological behavior of SKOV3 ovarian cancer cells. Molecular Medicine Reports. 24(4). 1 indexed citations
5.
Li, Ping, et al.. (2020). A novel inhibitory role of microRNA‐224 in particulate matter 2.5‐induced asthmatic mice by inhibiting TLR2. Journal of Cellular and Molecular Medicine. 24(5). 3040–3052. 31 indexed citations
6.
Guo, Fengjun, et al.. (2020). A novel GPCR target in correlation with androgen deprivation therapy for prostate cancer drug discovery. Basic & Clinical Pharmacology & Toxicology. 128(2). 195–203. 3 indexed citations
7.
Tian, Jingyan, Fengjun Guo, Yingying Chen, et al.. (2019). Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation. Cancer Letters. 448. 1–10. 53 indexed citations
8.
Guo, Fengjun, et al.. (2018). Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.. PubMed. 8(7). 1317–1331. 32 indexed citations
9.
Guo, Fengjun, et al.. (2017). Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities. Carcinogenesis. 39(3). 307–317. 34 indexed citations
10.
Guo, Fengjun, et al.. (2017). MIR-92 stimulates VEGF by inhibiting von Hippel-Lindau gene product in epithelial ovarian cancer.. PubMed. 31(3). 615–624. 9 indexed citations
11.
Jia, Yan, et al.. (2017). Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer. PLoS ONE. 12(8). e0183622–e0183622. 48 indexed citations
12.
Teng, Honglin, et al.. (2016). Microarray analysis of microRNA deregulation and angiogenesis-related proteins in endometriosis. Genetics and Molecular Research. 15(2). 49 indexed citations
13.
Guo, Fengjun, et al.. (2013). Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. Journal of International Medical Research. 41(5). 1456–1461. 56 indexed citations
14.
Guo, Fengjun, et al.. (2013). The Role of F-Fluorodeoxyglucose (FDG) Positron Emission Tomography–Computed Tomography (PET/CT) in the Screening of Cervical Cancer: A Literature Review. Cell Biochemistry and Biophysics. 69(2). 197–201. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026